Cancer Survivor Now Leads Research to Save Lives

When Fahmy Mamuya was 24 and starting a summer internship, unexplained abdominal pain turned his world upside down. The biology student went from playing soccer with friends to needing a full-body cast, and doctors struggled for two months to figure out why.

Scans finally revealed the culprit: a lesion on his spine caused by early-stage non-Hodgkin lymphoma. The diagnosis came with six months of weekly chemotherapy infusions followed by three months of radiation therapy.

The treatment worked. Mamuya survived and remains cancer-free today, more than two decades later.

But not everyone in those infusion chairs was so lucky. Seeing empty seats where friends once sat and receiving heartbreaking phone calls from their families changed everything for the young survivor.

After a year-long delay, Mamuya returned to college with a new mission. He earned his doctorate in Biological Sciences from the University of Delaware, then completed a postdoctoral fellowship at Massachusetts General Hospital and Harvard Medical School.

Today, Dr. Mamuya leads translational research developing cancer biomarkers and liquid biopsy technologies at the University of Connecticut Health Technology Program. His work focuses on early detection and precision medicine, the kinds of advances that could help future patients catch cancer sooner.

He also serves as Ambassador Team Lead for the American Cancer Society Cancer Action Network. There, he lobbies policymakers to improve access to biomarker testing and develops volunteer advocacy programs that support patients and survivors.

The Ripple Effect

Mamuya's journey from patient to researcher shows how personal experience can fuel professional purpose. His work on liquid biopsy technologies could make cancer screening easier and more accessible for millions of patients.

Through his advocacy role, he's helping shape policies that expand access to cutting-edge cancer care. The organization that supported him during his darkest days now benefits from his expertise and passion.

What started as a personal tragedy has become a career dedicated to ensuring other patients get what he received: a fighting chance at survival and a future beyond cancer.

At 46, Dr. Mamuya carries forward the memory of those empty infusion chairs by working to fill them with survivors instead.